[{"data":1,"prerenderedAt":217},["ShallowReactive",2],{"drug-isosorbide-dinitrate":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":60,"contraindications":98,"warnings":108,"renal":109,"monitoring":110,"interactions":111,"review":112,"examples":115,"atc":121,"iran":123,"links":159,"populations":178,"usApproval":212},"isosorbide-dinitrate",1,{"fa":7,"en":8},"ایزوسورباید دی‌نیترات","Isosorbide dinitrate","cardiovascular",{"fa":11,"en":12},"نیترات","Nitrate",[14],{"name":15,"market":16},"Isordil","US",[18,19,20,11],"isordil","ایزوردیل","ایزوسورباید",[22,36,44,52],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":31,"refs":32},"tab-5","tablet","oral","5 mg tablet (scored)",{"amount":28,"unit":29,"perUnit":24,"scored":30},5,"mg",true,[16],[33],{"source":34,"section":35},"fda-isdn","How Supplied",{"id":37,"form":24,"route":25,"label":38,"concentration":39,"markets":41,"refs":42},"tab-10","10 mg tablet (scored)",{"amount":40,"unit":29,"perUnit":24,"scored":30},10,[16],[43],{"source":34,"section":35},{"id":45,"form":24,"route":25,"label":46,"concentration":47,"markets":49,"refs":50},"tab-20","20 mg tablet (scored)",{"amount":48,"unit":29,"perUnit":24,"scored":30},20,[16],[51],{"source":34,"section":35},{"id":53,"form":24,"route":25,"label":54,"concentration":55,"markets":57,"refs":58},"tab-30","30 mg tablet (scored)",{"amount":56,"unit":29,"perUnit":24,"scored":30},30,[16],[59],{"source":34,"section":35},[61,83],{"id":62,"disease":62,"label":63,"population":66,"type":70,"unit":29,"dose":71,"refs":73,"notes":76},"angina",{"fa":64,"en":65},"پیشگیری از آنژین — شروع ۵ تا ۲۰ mg دو یا سه بار در روز","Angina prevention — start 5–20 mg two or three times daily",{"minAge":67},{"value":68,"unit":69},18,"year","fixed",{"perDose":28,"perDoseMax":48,"dosesPerDay":72},2,[74],{"source":34,"section":75},"Dosage and Administration",[77],{"text":78,"refs":81},{"fa":79,"en":80},"نگهدارنده ۱۰ تا ۴۰ mg دو یا سه بار در روز.","Maintenance 10–40 mg two or three times daily.",[82],{"source":34,"section":75},{"id":84,"disease":62,"label":85,"population":88,"type":90,"unit":29,"dose":91,"refs":95},"peds",{"fa":86,"en":87},"زیر ۱۸ سال","Under 18 years",{"maxAge":89},{"value":68,"unit":69},"notCalculated",{"reason":92},{"fa":93,"en":94},"بی‌خطری و اثربخشی در کودکان ثابت نشده است.","Safety and effectiveness in pediatric patients not established.",[96],{"source":34,"section":97},"Pediatric Use",[99],{"id":100,"severity":101,"text":102,"refs":105},"ci","block",{"fa":103,"en":104},"حساسیت به ایزوسورباید دی‌نیترات.","Allergy to isosorbide dinitrate.",[106],{"source":34,"section":107},"Contraindications",[],[],[],[],{"status":113,"reviewer":114,"date":114},"unverified",null,[116],{"regimen":62,"formulation":23,"input":117,"expect":120},{"ageYears":118,"weightKg":119},60,80,{"perDose":28,"upperPerDose":48},[122],"C01DA08",{"status":124,"forms":125,"refs":154},"registered",[126,130,134,138,142,146,150],{"code":127,"en":128,"fa":129},"18954","ISOSORBIDE DINITRATE 1.25MG\u002FDOSE SPRAY","اسپری ایزوسورباید دی‌نیترات ۱٫۲۵ میلی‌گرم \u002F دوز",{"code":131,"en":132,"fa":133},"00717","ISOSORBIDE DINITRATE 10MG TAB","قرص ایزوسورباید دی‌نیترات ۱۰ میلی‌گرم",{"code":135,"en":136,"fa":137},"01559","ISOSORBIDE DINITRATE 20MG SR TAB","قرص آهسته‌رهش ایزوسورباید دی‌نیترات ۲۰ میلی‌گرم",{"code":139,"en":140,"fa":141},"00718","ISOSORBIDE DINITRATE 40MG SR TAB","قرص آهسته‌رهش ایزوسورباید دی‌نیترات ۴۰ میلی‌گرم",{"code":143,"en":144,"fa":145},"06506","ISOSORBIDE DINITRATE 40MG TAB","قرص ایزوسورباید دی‌نیترات ۴۰ میلی‌گرم",{"code":147,"en":148,"fa":149},"00719","ISOSORBIDE DINITRATE 5MG TAB","قرص ایزوسورباید دی‌نیترات ۵ میلی‌گرم",{"code":151,"en":152,"fa":153},"05968","ISOSORBIDE DINITRATE 60MG SR TAB","قرص آهسته‌رهش ایزوسورباید دی‌نیترات ۶۰ میلی‌گرم",[155],{"source":156,"section":157,"url":158},"darooyab-generic","G-1721\u002FIsosorbide-Dinitrate","https:\u002F\u002Fwww.darooyab.ir\u002FG-1721\u002FIsosorbide-Dinitrate",[160,164,168,172,175],{"kind":161,"url":162,"label":163},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=086923","ANDA086923",{"kind":165,"url":166,"label":167},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=6df6a2fa-c56c-4eb6-a485-c16585420eb0","FDA Isosorbide dinitrate",{"kind":169,"url":170,"label":171},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa682348.html","Isosorbide",{"kind":173,"url":174,"label":122},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=C01DA08",{"kind":176,"url":158,"label":177},"darooyab","Isosorbide-Dinitrate",{"pregnancy":179,"lactation":188,"pediatric":196,"geriatric":204},{"level":180,"text":181,"quote":184,"refs":185},"caution",{"fa":182,"en":183},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Isosorbide dinitrate should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.",[186],{"source":34,"section":187},"Pregnancy Category C",{"level":180,"text":189,"quote":192,"refs":193},{"fa":190,"en":191},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Because many drugs are excreted in human milk, caution should be exercised when isosorbide dinitrate is administered to a nursing woman.",[194],{"source":34,"section":195},"Nursing Mothers",{"level":197,"text":198,"quote":201,"refs":202},"not-established",{"fa":199,"en":200},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","Safety and effectiveness in pediatric patients have not been established.",[203],{"source":34,"section":97},{"level":180,"text":205,"quote":208,"refs":209},{"fa":206,"en":207},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.",[210],{"source":34,"section":211},"Geriatric Use",{"kind":213,"refs":214,"id":163},"ANDA",[215],{"source":34,"section":216},"SPL approval \u002F marketing category",1792440727212]